The role of endothelin receptor antagonists in kidney disease. [PDF]
Ma X+5 more
europepmc +1 more source
Emerging antihypertensive therapies and cardiovascular, kidney, and metabolic outcomes: a Mendelian randomization study. [PDF]
Le NN+4 more
europepmc +1 more source
Influence of Atherosclerosis-Associated Risk Factors on Expression of Endothelin Receptors in Advanced Atherosclerosis. [PDF]
Herbers O+7 more
europepmc +1 more source
Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs). [PDF]
He Q+11 more
europepmc +1 more source
Sotatercept: A Crosstalk Between Pathways and Activities in the Pulmonary Circulation and Blood. [PDF]
Madonna R, Ghelardoni S.
europepmc +1 more source
Aprocitentan in hypertension management: clinical efficacy, safety, and future prospects. [PDF]
Riaz R+6 more
europepmc +1 more source
Precision Treatment of IgA Nephropathy Based on a New Framework: Angiorenal Protection, Immunity Inhibition, B-Cell/Plasma-Cell Modulation, and Complement Inhibition. [PDF]
Xue C, Yu S, Gou W, Xu Y, Yang L, Dai B.
europepmc +1 more source
ThoroughFare atrial pressure controller device to create a controlled interatrial right-to-left shunt in advanced pulmonary arterial hypertension - A pilot study. [PDF]
Roopesh BVS+7 more
europepmc +1 more source